Wuhan Keqian Biology (688526.SS) Earnings Analysis
Wuhan Keqian Biology (688526.SS) next reports earnings on 2026-08-27. Trailing P/E 15.06.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688526.SS next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.23B |
688526.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-27 | 0.17 CNY | n/a | n/a | n/a |
| 2025-10-30 | 0.2541 CNY | n/a | n/a | n/a |
| 2025-02-26 | 0.2387 CNY | n/a | n/a | n/a |
| 2024-08-29 | 0.1408 CNY | n/a | n/a | n/a |
688526.SS valuation and analyst view
| Trailing P/E | 15.06 |
|---|---|
| Trailing EPS | 0.83614 CNY |
| Price / book | 1.37 |
| Dividend yield | 5.06% |
| Market cap | 5.86B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Wuhan Keqian Biology (688526.SS)'s next earnings date?
Wuhan Keqian Biology is next scheduled to report on 2026-08-27 and revenue estimate of 0.23B.
Did 688526.SS beat earnings last quarter?
Consensus estimate data was not available for 688526.SS's 2026-02-27 report.
What is 688526.SS's current P/E ratio and EPS?
688526.SS trades at a trailing P/E of 15.06 on trailing EPS of 0.8361436537022797 CNY.
What do analysts rate 688526.SS?
688526.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.